Based on the histological status of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67, breast cancer can be divided into Luminal A, Luminal B, HER2-positive and triple-negative subtype [2]. This evidence concerns the gene ESR1 and breast carcinoma.